enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Management of Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Management_of_Parkinson's...

   Pharmacological treatment of Parkinson's disease. The main families of drugs useful for treating motor symptoms are levodopa, dopamine agonists, and MAO-B inhibitors. [3] The most commonly used treatment approach varies depending on the disease stage.

3. Category:Antiparkinsonian agents - Wikipedia

   en.wikipedia.org/wiki/Category:Antiparkinsonian...

   Generally, drugs outlined within the ATC code N04 should be included in this category. Please see WP:PHARM:CAT for more information. Wikimedia Commons has media related to Antiparkinsonian agents .

4. Rasagiline - Wikipedia

   en.wikipedia.org/wiki/Rasagiline

   Rasagiline, sold under the brand name Azilect among others, is a medication which is used in the treatment of Parkinson's disease. [2] [6] It is used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. [7]

5. Dopamine agonist - Wikipedia

   en.wikipedia.org/wiki/Dopamine_agonist

   Dopamine agonists are mainly used in the treatment of Parkinson's disease. [2] The cause of Parkinson's is not fully known but genetic factors, for example specific genetic mutations, and environmental triggers have been linked to the disease. [4] In Parkinson's disease dopaminergic neurons that produce the neurotransmitter dopamine in the ...

6. Amantadine - Wikipedia

   en.wikipedia.org/wiki/Amantadine

   Amantadine may be used alone or in combination with another anti-Parkinson's or anticholinergic drug. [20] The specific symptoms targeted by amantadine therapy are dyskinesia and rigidity. [19] The extended release amantadine formulation is commonly used to treat dyskinesias in people receiving levodopa therapy for Parkinson's disease. [19]

7. Type 2 diabetes drugs could lower dementia, Parkinson's ... - AOL

   www.aol.com/type-2-drugs-could-lower-133000670.html

   Researchers from Yonsei University College of Medicine in Seoul showed that Alzheimer’s disease, Parkinson’s disease, and dementia risk, in general, were reduced by about 20% in people with ...